• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy.CRISPR-Cas9基因编辑疗法引发的1型人类免疫缺陷病毒亚型特异性脱靶效应的预测
CRISPR J. 2018 Aug;1(4):294-302. doi: 10.1089/crispr.2018.0020.
2
Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.多重串联的猴免疫缺陷病毒特异性 RNA 引导的 Cas9 切口酶使前病毒 DNA 失活。
J Virol. 2021 Nov 9;95(23):e0088221. doi: 10.1128/JVI.00882-21. Epub 2021 Sep 22.
3
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.CRISPR/Cas9 靶向整合的 HIV-1 会导致前病毒 DNA 环与重组长末端重复序列积累。
J Virol. 2021 Nov 9;95(23):e0135821. doi: 10.1128/JVI.01358-21. Epub 2021 Sep 22.
4
HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.利用CRISPR/Cas9技术切除HIV:攻击储存库中的前病毒准种以实现治愈
MOJ Immunol. 2014 Oct 17;1(4). doi: 10.15406/moji.2014.01.00022.
5
Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.病毒多样性是针对 HIV 储存库的 CRISPR/Cas9 设计中必须考虑的因素。
BMC Biol. 2018 Jul 11;16(1):75. doi: 10.1186/s12915-018-0544-1.
6
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.通过靶向长末端重复序列(LTR)的核因子κB(NF-κB)结合位点,利用CRISPR-Cas9对HIV-1进行安全、高特异性和广谱活性的抑制
Mol Ther Nucleic Acids. 2020 Sep 4;21:965-982. doi: 10.1016/j.omtn.2020.07.016. Epub 2020 Jul 15.
7
CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.CRISPR/Cas9 系统靶向 HIV-1 的调节基因,抑制感染 T 细胞培养物中的病毒复制。
Sci Rep. 2018 May 17;8(1):7784. doi: 10.1038/s41598-018-26190-1.
8
Negative Feedback Regulation of HIV-1 by Gene Editing Strategy.通过基因编辑策略对 HIV-1 的负反馈调节。
Sci Rep. 2016 Aug 16;6:31527. doi: 10.1038/srep31527.
9
Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9.在含有病毒靶序列、相应引导RNA(gRNA)和CRISPR/Cas9的细胞中评估抗HIV-1引导RNA的功效。
Front Genome Ed. 2023 Apr 13;5:1101483. doi: 10.3389/fgeed.2023.1101483. eCollection 2023.
10
CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.基于CRISPR/Cas9的多重基因组编辑及其应用
Prog Mol Biol Transl Sci. 2017;149:111-132. doi: 10.1016/bs.pmbts.2017.05.003. Epub 2017 Jun 20.

引用本文的文献

1
Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity.Cas9表达的时间限制提高了CRISPR介导的缺失效率和保真度。
Mol Ther Nucleic Acids. 2024 Mar 11;35(2):102172. doi: 10.1016/j.omtn.2024.102172. eCollection 2024 Jun 11.
2
Delivering CRISPR to the HIV-1 reservoirs.将CRISPR技术应用于HIV-1病毒库。
Front Microbiol. 2024 May 15;15:1393974. doi: 10.3389/fmicb.2024.1393974. eCollection 2024.
3
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy.迈向功能性 HIV-1 治愈的途径:平衡 CRISPR 治疗的前景与风险。
Methods Mol Biol. 2022;2407:429-445. doi: 10.1007/978-1-0716-1871-4_27.
4
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy.基因编辑中的脱靶分析以及CRISPR/Cas9在HIV-1治疗临床转化中的应用
Front Genome Ed. 2021 Aug 17;3:673022. doi: 10.3389/fgeed.2021.673022. eCollection 2021.
5
HIV-1 cure strategies: why CRISPR?HIV-1 治愈策略:为何选择 CRISPR?
Expert Opin Biol Ther. 2021 Jun;21(6):781-793. doi: 10.1080/14712598.2021.1865302. Epub 2021 Feb 7.
6
Multiplexed -Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape.多重靶向 CRISPR-Cas9 保护 T 细胞免受急性 HIV-1 感染,抑制病毒逃逸。
Viruses. 2020 Oct 28;12(11):1223. doi: 10.3390/v12111223.
7
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing.设计更安全的用于治疗HIV的CRISPR/Cas9疗法:确定调控脱靶编辑的因素及用于检测脱靶编辑的技术
Front Microbiol. 2020 Aug 12;11:1872. doi: 10.3389/fmicb.2020.01872. eCollection 2020.
8
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients.新型 gRNA 设计流程,用于开发广谱 CRISPR/Cas9 gRNA,以安全靶向患者 HIV-1 准种。
Sci Rep. 2019 Nov 19;9(1):17088. doi: 10.1038/s41598-019-52353-9.
9
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.关于 DNA 可及性对 CRISPR-Cas9 切割效率影响的计算分析。
Mol Ther. 2020 Jan 8;28(1):19-28. doi: 10.1016/j.ymthe.2019.10.008. Epub 2019 Oct 15.
10
Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.研究德雷塞尔医学关怀队列中存在的 HIV-1 Tat 长度分布。
Virus Res. 2019 Oct 15;272:197727. doi: 10.1016/j.virusres.2019.197727. Epub 2019 Aug 19.

本文引用的文献

1
Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.用于CRISPR/Cas9 HIV-1治疗的广谱和个性化引导RNA
AIDS Res Hum Retroviruses. 2018 Nov;34(11):950-960. doi: 10.1089/AID.2017.0274. Epub 2018 Aug 27.
2
Chromatin accessibility is associated with CRISPR-Cas9 efficiency in the zebrafish (Danio rerio).染色质可及性与斑马鱼(Danio rerio)中 CRISPR-Cas9 效率相关。
PLoS One. 2018 Apr 23;13(4):e0196238. doi: 10.1371/journal.pone.0196238. eCollection 2018.
3
Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site.转录起始位点下游CCAAT/增强子结合蛋白位点的功能研究
Clin Med Insights Pathol. 2017 Nov 15;10:1179555717694556. doi: 10.1177/1179555717694556. eCollection 2017.
4
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.设计广谱抗 HIV-1 gRNAs 以靶向患者来源的变异体。
Sci Rep. 2017 Oct 31;7(1):14413. doi: 10.1038/s41598-017-12612-z.
5
Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.通过 CRISPR/Cas9 同时敲除 CD4+ T 细胞中的 CXCR4 和 CCR5 基因可抵抗 X4 和 R5 嗜性的人类免疫缺陷病毒 1 型感染。
Hum Gene Ther. 2018 Jan;29(1):51-67. doi: 10.1089/hum.2017.032. Epub 2017 Jun 9.
6
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.CRISPR/Cas9介导的人类造血干细胞/祖细胞中CCR5基因敲除在体内赋予对HIV-1的抗性
Mol Ther. 2017 Aug 2;25(8):1782-1789. doi: 10.1016/j.ymthe.2017.04.027. Epub 2017 May 17.
7
CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets.CIRCLE-seq:一种用于全基因组CRISPR-Cas9核酸酶脱靶的高灵敏度体外筛选方法。
Nat Methods. 2017 Jun;14(6):607-614. doi: 10.1038/nmeth.4278. Epub 2017 May 1.
8
The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.染色质动力学对人类细胞中Cas9介导的基因组编辑的影响
ACS Synth Biol. 2017 Mar 17;6(3):428-438. doi: 10.1021/acssynbio.5b00299. Epub 2016 Nov 17.
9
Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication.CRISPR/Cas9系统的抗HIV-1效力不足以完全抑制病毒复制。
Microbiol Immunol. 2016 Jul;60(7):483-96. doi: 10.1111/1348-0421.12395.
10
HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.在病毒载量得到良好抑制的患者外周血中,仍不断发现导致新准种形成的HIV-1基因变异。
PLoS One. 2016 May 19;11(5):e0155382. doi: 10.1371/journal.pone.0155382. eCollection 2016.

CRISPR-Cas9基因编辑疗法引发的1型人类免疫缺陷病毒亚型特异性脱靶效应的预测

Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy.

作者信息

Link Robert W, Nonnemacher Michael R, Wigdahl Brian, Dampier Will

机构信息

1 School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania.

2 Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania.

出版信息

CRISPR J. 2018 Aug;1(4):294-302. doi: 10.1089/crispr.2018.0020.

DOI:10.1089/crispr.2018.0020
PMID:31021222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6553478/
Abstract

Chronic human immunodeficiency virus type 1 (HIV-1) disease is characterized by the retention of provirus within latently infected cells. Anti-HIV-1 CRISPR-Cas9 gene editing is an attractive strategy to excise or inactivate the HIV-1 genome. Recent strategies have focused on designing gRNAs that target the long terminal repeat (LTR) because 5' and 3' LTR symmetry can facilitate proviral excision. However, the promiscuity of CRISPR-Cas9 gene editing system necessitates the investigation of potential off-target effects. Here, potential gRNAs designed from HIV-1 phylogenetic subtypes using the CRISPRseek tool were investigated. Across the LTR, it was found that certain regions show higher human homology than others. When using recommended cutoffs, 96.40% of gRNAs were predicted to have no high probability off-target effects. Given this observation, while high-probability off-target effects are a potential danger, they can be avoided with proper gRNA design.

摘要

慢性1型人类免疫缺陷病毒(HIV-1)疾病的特征是原病毒保留在潜伏感染的细胞内。抗HIV-1 CRISPR-Cas9基因编辑是切除或使HIV-1基因组失活的一种有吸引力的策略。最近的策略集中在设计靶向长末端重复序列(LTR)的引导RNA(gRNA),因为5'和3' LTR的对称性有助于前病毒的切除。然而,CRISPR-Cas9基因编辑系统的混杂性使得有必要研究潜在的脱靶效应。在此,对使用CRISPRseek工具从HIV-1系统发育亚型设计的潜在gRNA进行了研究。在整个LTR中,发现某些区域的人类同源性高于其他区域。使用推荐的临界值时,预计96.40%的gRNA没有高概率的脱靶效应。基于这一观察结果,虽然高概率脱靶效应是一个潜在危险,但通过适当的gRNA设计可以避免。